Of nine nonsuppressors on the dexamethasone suppression test (DST), five
(56%) developed intolerable side effects during treatment with fluvoxamine,
a new serotonin uptake inhibiting antidepressant, compared with three of 24
suppressors (13%).Abstract Teaser